{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:03:09Z","timestamp":1792735389714,"version":"4.5.0"},"reference-count":77,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2017,9,29]]},"DOI":"10.3233\/jhd-170253","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T11:17:33Z","timestamp":1506683853000},"page":"179-188","source":"Crossref","is-referenced-by-count":49,"title":["Huntington\u2019s Disease and Diabetes: Chronological Sequence of its Association"],"prefix":"10.1177","volume":"6","author":[{"given":"Mar\u00eda Teresa","family":"Montojo","sequence":"first","affiliation":[{"name":"Department of Neurology, Movement Disorders Unit, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Aganzo","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Renal, Vascular and Diabetes Research Laboratory, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Aut\u00f3noma University, Madrid, Spain"},{"name":"Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) network, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-170253_ref1","first-page":"317","article-title":"On chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"Med Surg Report Philadelphia"},{"key":"10.3233\/JHD-170253_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-19285-7_1","article-title":"The neuropathology of Huntington's disease: Classical findings, recent developments and correlation to functional neuroanatomy","volume":"217","author":"R\u00fcb","year":"2015","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.3233\/JHD-170253_ref3","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u201383. (http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8458085) (accessed June 14, 2016).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.3233\/JHD-170253_ref4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.3233\/JHD-170253_ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of Genetic factors that modify clinical onset of Huntington\u2019s disease","volume":"162","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium","year":"2015","journal-title":"Cell"},{"key":"10.3233\/JHD-170253_ref6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jad.2013.06.001","article-title":"Suicidal ideation in a European Huntington\u2019s disease population","volume":"151","author":"Hubers","year":"2013","journal-title":"J Affect Disord"},{"key":"10.3233\/JHD-170253_ref7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/13543784.2016.1153627","article-title":"Pridopidine for the treatment of Huntington\u2019s disease","volume":"25","author":"Shannon","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JHD-170253_ref8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","article-title":"Formation of polyglutamine inclusions in non-CNS tissue","volume":"8","author":"Sathasivam","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-170253_ref9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00726-017-2417-2","article-title":"Glucose transportation in the brain and its impairment in Huntington disease: One more shade of the energetic metabolism failure?","volume":"49","author":"Morea","year":"2017","journal-title":"Amino Acids"},{"issue":"11-12","key":"10.3233\/JHD-170253_ref10","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington\u2019s disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.3233\/JHD-170253_ref11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington\u2019s disease","volume":"24","author":"Peters\u00e9n","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JHD-170253_ref12","first-page":"4 e4962","article-title":"Neuroendocrine disturbances in Huntington\u2019s disease","author":"Saleh","year":"2009","journal-title":"PLoS One"},{"key":"10.3233\/JHD-170253_ref13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"Farrer","year":"1985","journal-title":"Clin Genet"},{"key":"10.3233\/JHD-170253_ref14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","article-title":"Increased frequency of diabetes mellitus in patients with Huntington\u2019s chorea","volume":"1","author":"Podolsky","year":"1972","journal-title":"Lancet"},{"key":"10.3233\/JHD-170253_ref15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","article-title":"Neurodegenerative disorders associated with diabetes mellitus","volume":"82","author":"Ristow","year":"2004","journal-title":"J Mol Med"},{"key":"10.3233\/JHD-170253_ref16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","article-title":"Risk of dementia among persons with diabetes mellitus: A population-based cohort study","volume":"145","author":"Leibson","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JHD-170253_ref17","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","article-title":"Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity","volume":"87","author":"H\u00f6ybye","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JHD-170253_ref18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington\u2019s disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"10.3233\/JHD-170253_ref19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington\u2019s disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-170253_ref20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington\u2019s disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"Bj\u00f6rkqvist","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-170253_ref21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington\u2019s disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp Brain Res"},{"key":"10.3233\/JHD-170253_ref22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamda.2014.01.010","article-title":"Clinical, demographic, and pharmacologic features of nursing home residents with Huntington\u2019s disease","volume":"15","author":"Zarowitz","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.3233\/JHD-170253_ref23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front Physiol"},{"key":"10.3233\/JHD-170253_ref24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0022-510X(89)90120-2","article-title":"Endocrine functions in Huntington\u2019s disease. A two-and-a-half years follow-up study","volume":"90","author":"Kremer","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.3233\/JHD-170253_ref25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","article-title":"Huntington\u2019s disease does not appear to increase the risk of diabetes mellitus","volume":"21","author":"Boesgaard","year":"2009","journal-title":"J Neuroendocrinol"},{"key":"10.3233\/JHD-170253_ref26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1192\/bjp.103.432.507","article-title":"Some observations on Huntington\u2019s chorea","volume":"103","author":"Forrest","year":"1957","journal-title":"J Ment Sci"},{"key":"10.3233\/JHD-170253_ref27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0079-6123(08)64080-7","article-title":"Biogenic amines in the hypothalamus: Effect of L-DOPA on human growth hormone levels in patients with Huntington\u2019s chorea","volume":"39","author":"Podolsky","year":"1973","journal-title":"Prog Brain Res"},{"key":"10.3233\/JHD-170253_ref28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jcem-39-1-36","article-title":"Growth hormone abnormalities in Huntington\u2019s chorea: Effect of L-dopa administration","volume":"39","author":"Podolsky","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JHD-170253_ref29","first-page":"489","article-title":"Metabolic disorders in Huntington\u2019s chorea","volume":"78","author":"Insarova","year":"1978","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"key":"10.3233\/JHD-170253_ref30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01851645","article-title":"Fatty acid patterns and glucose tolerance in Huntington\u2019s chorea","volume":"167","author":"Schubotz","year":"1976","journal-title":"Res Exp Med (Berl)"},{"key":"10.3233\/JHD-170253_ref31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.39.3.244","article-title":"Altered growth hormone release in Huntington\u2019s chorea","volume":"39","author":"Keogh","year":"1976","journal-title":"J Neurol Neurosur Psychiatry"},{"key":"10.3233\/JHD-170253_ref32","first-page":"807","article-title":"Normal glucose, insulin, and growth hormone responses to oral glucose in Huntington's disease","volume":"81","author":"Davidson","year":"1974","journal-title":"J Lab Clin Med"},{"key":"10.3233\/JHD-170253_ref33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/jnnp.44.5.414","article-title":"Studies of hypothalamic function in Huntington\u2019s chorea","volume":"44","author":"Lavin","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-170253_ref34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.3233\/JHD-170253_ref35","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JHD-170253_ref36","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JHD-170253_ref37","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: Parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-170253_ref38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-170253_ref39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","article-title":"Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"20","author":"Josefsen","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.3233\/JHD-170253_ref40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington\u2019s in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.3233\/JHD-170253_ref41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","article-title":"Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington\u2019s disease mutation","volume":"10","author":"Fain","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-170253_ref42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington\u2019s disease: Behavioral testing and impact of diabetes mellitus","volume":"126","author":"L\u00fcesse","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.3233\/JHD-170253_ref43","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1046\/j.1471-4159.2000.0742108.x","article-title":"Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington\u2019s disease mice","volume":"74","author":"Jenkins","year":"2000","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-170253_ref44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/diacare.15.10.1413","article-title":"Stress and diabetes mellitus","volume":"15","author":"Surwit","year":"1992","journal-title":"Diabetes Care"},{"key":"10.3233\/JHD-170253_ref45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocr Rev"},{"key":"10.3233\/JHD-170253_ref46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1525-0016(03)00063-7","article-title":"DNA vaccination against mutant huntingtin ameliorates the HDR6\/2 diabetic phenotype","volume":"7","author":"Miller","year":"2003","journal-title":"Mol Ther"},{"key":"10.3233\/JHD-170253_ref47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","article-title":"Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse","volume":"76","author":"Wood","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.3233\/JHD-170253_ref48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington\u2019s disease mutation","volume":"29","author":"Morton","year":"2000","journal-title":"J Neurocytol"},{"key":"10.3233\/JHD-170253_ref49","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1093\/hmg\/ddp336","article-title":"Mutant huntingtin interacts with beta-tubulin and disrupts vesicular transport and insulin secretion","volume":"18","author":"Smith","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-170253_ref50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.1085","article-title":"Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington\u2019s disease","volume":"50","author":"Andreassen","year":"2001","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.3233\/JHD-170253_ref51","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.2337\/diabetes.50.2007.S154","article-title":"Beta-cell adaptation and decompensation during the progression of diabetes","volume":"50","author":"Weir","year":"2001","journal-title":"Diabetes"},{"key":"10.3233\/JHD-170253_ref52","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1172\/JCI46305","article-title":"IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease","volume":"121","author":"Sadagurski","year":"2011","journal-title":"J Clin Invest"},{"key":"10.3233\/JHD-170253_ref53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.110.166470","article-title":"Transferrin fusion technology: A novel approach to prolonging biological half-life of insulinotropic peptides","volume":"334","author":"Kim","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JHD-170253_ref54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease","volume":"225","author":"Ho","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-170253_ref55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.3233\/JHD-170253_ref56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.3233\/JHD-170253_ref57","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1210\/jcem.87.3.8337","article-title":"The insulinotropic effect of acute exendin-4 administered to humans: Comparison of nondiabetic state to type 2 diabetes","volume":"87","author":"Egan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JHD-170253_ref58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000338464","article-title":"Glucagon-like peptide-1 agonist exendin-4 leads to reduction of weight and caloric intake in a rat model of hypothalamic obesity","volume":"78","author":"Elfers","year":"2012","journal-title":"Horm Res. P\u00e6diatrics"},{"key":"10.3233\/JHD-170253_ref59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington\u2019s disease","volume":"411","author":"Ma","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-170253_ref60","doi-asserted-by":"crossref","first-page":"31766","DOI":"10.1074\/jbc.M112.387316","article-title":"Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy","volume":"287","author":"Martin","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-170253_ref61","doi-asserted-by":"crossref","first-page":"43030","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington\u2019s disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-170253_ref62","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M304615200","article-title":"Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II","volume":"278","author":"Edwardson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-170253_ref63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: Abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lali\u0107","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-170253_ref64","doi-asserted-by":"crossref","first-page":"e0146480","DOI":"10.1371\/journal.pone.0146480","article-title":"A Metabolic study of Huntington\u2019s disease","volume":"11","author":"Nambron","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JHD-170253_ref65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JHD-130078","article-title":"Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington\u2019s disease patients","volume":"2","author":"Russo","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-170253_ref66","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1331.2009.02798.x","article-title":"Growth hormone and ghrelin secretion are associated with clinical severity in Huntington\u2019s disease","volume":"17","author":"Aziz","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.3233\/JHD-170253_ref67","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1073\/pnas.1402663111","article-title":"Effect of sleep deprivation on the human metabolome","volume":"111","author":"Davies","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JHD-170253_ref68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","article-title":"Metabolic disturbances in plasma as biomarkers for Huntington\u2019s disease","volume":"31","author":"Cheng","year":"2016","journal-title":"J Nut. Biochem"},{"key":"10.3233\/JHD-170253_ref69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2016.05.005","article-title":"Circulating microRNAs in Huntington\u2019s disease: Emerging mediators in metabolic impairment","volume":"108","author":"D\u00edez-Planelles","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.3233\/JHD-170253_ref70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-120044","article-title":"Proteomic analysis of the human brain in Huntington\u2019s Disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes","volume":"2","author":"Sch\u00f6nberger","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-170253_ref71","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00418-008-0393-z","article-title":"Islet beta-cell area and hormone expression are unaltered in Huntington\u2019s disease","volume":"129","author":"Bacos","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.3233\/JHD-170253_ref72","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1592\/phco.22.11.841.33629","article-title":"Olanzapine-associated diabetes mellitus","volume":"22","author":"Koller","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.3233\/JHD-170253_ref73","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-131847","article-title":"High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington\u2019s disease","volume":"40","author":"Hu","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JHD-170253_ref74","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archneur.62.6.995","article-title":"Monozygotic twins discordant for Huntington disease after 7 years","volume":"62","author":"Friedman","year":"2005","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-170253_ref75","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1210\/jc.2012-1190","article-title":"Hyperglycemic chorea-ballism or acute exacerbation of Huntington\u2019s chorea? Huntington\u2019s disease unmasked by diabetic ketoacidosis in type 1 diabetes mellitus","volume":"97","author":"Hashimoto","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JHD-170253_ref76","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/mds.23176","article-title":"Impaired insulin sensitivity and secretion in normoglycemic patients with spinocerebellar ataxia type 1","volume":"25","author":"Lali\u0107","year":"2010","journal-title":"Mov. Disord"},{"key":"10.3233\/JHD-170253_ref77","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/diabetes.47.10.1654","article-title":"No association between the Friedreich\u2019s ataxia gene and NIDDM in the French population","volume":"47","author":"Dupont","year":"1998","journal-title":"Diabetes"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-170253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:19Z","timestamp":1777453039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-170253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":77,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jhd-170253","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}